BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34048161)

  • 1. Impact of Underlying Comorbidities on Mortality in SARS-COV-2 Infected Cancer Patients: A Systematic Review and Meta-Analysis.
    Kaur H; Thakur JS; Paika R; Advani SM
    Asian Pac J Cancer Prev; 2021 May; 22(5):1333-1349. PubMed ID: 34048161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis.
    Ng WH; Tipih T; Makoah NA; Vermeulen JG; Goedhals D; Sempa JB; Burt FJ; Taylor A; Mahalingam S
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
    Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
    Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
    Bajgain KT; Badal S; Bajgain BB; Santana MJ
    Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer: A Systematic Review and Meta-analysis.
    Khoury E; Nevitt S; Madsen WR; Turtle L; Davies G; Palmieri C
    JAMA Netw Open; 2022 May; 5(5):e2210880. PubMed ID: 35532936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
    Yin T; Li Y; Ying Y; Luo Z
    BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related risk factors and severity of SARS-CoV-2 infection: a systematic review and meta-analysis.
    Rahman MM; Bhattacharjee B; Farhana Z; Hamiduzzaman M; Chowdhury MAB; Hossain MS; Siddiqee MH; Islam MZ; Raheem E; Uddin MJ
    J Prev Med Hyg; 2021 Jun; 62(2):E329-E371. PubMed ID: 34604574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis.
    Khan MMA; Khan MN; Mustagir MG; Rana J; Islam MS; Kabir MI
    J Glob Health; 2020 Dec; 10(2):020503. PubMed ID: 33110586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis.
    Harwood R; Yan H; Talawila Da Camara N; Smith C; Ward J; Tudur-Smith C; Linney M; Clark M; Whittaker E; Saatci D; Davis PJ; Luyt K; Draper ES; Kenny SE; Fraser LK; Viner RM
    EClinicalMedicine; 2022 Feb; 44():101287. PubMed ID: 35169689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression.
    Chenchula S; Vidyasagar K; Pathan S; Sharma S; Chavan MR; Bhagavathula AS; Padmavathi R; Manjula M; Chhabra M; Gupta R; Amerneni KC; Ghanta MK; Mudda S
    Sci Rep; 2023 Apr; 13(1):6415. PubMed ID: 37076543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients.
    Dessie ZG; Zewotir T
    BMC Infect Dis; 2021 Aug; 21(1):855. PubMed ID: 34418980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiological burden and overall distribution of chronic comorbidities in coronavirus disease-2019 among 202,005 infected patients: evidence from a systematic review and meta-analysis.
    Mahumud RA; Kamara JK; Renzaho AMN
    Infection; 2020 Dec; 48(6):813-833. PubMed ID: 32813220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of SARS-CoV-2 infections in patients with cancer on mortality, ICU admission and incidence: a systematic review with meta-analysis involving 709,908 participants and 31,732 cancer patients.
    Arayici ME; Kipcak N; Kayacik U; Kelbat C; Keskin D; Kilicarslan ME; Kilinc AV; Kirgoz S; Kirilmaz A; Kizilkaya MA; Kizmaz IG; Kocak EB; Kochan E; Kocpinar B; Kordon F; Kurt B; Ellidokuz H
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):2915-2928. PubMed ID: 35831763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies.
    Parohan M; Yaghoubi S; Seraji A; Javanbakht MH; Sarraf P; Djalali M
    Aging Male; 2020 Dec; 23(5):1416-1424. PubMed ID: 32508193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study.
    Jassat W; Cohen C; Tempia S; Masha M; Goldstein S; Kufa T; Murangandi P; Savulescu D; Walaza S; Bam JL; Davies MA; Prozesky HW; Naude J; Mnguni AT; Lawrence CA; Mathema HT; Zamparini J; Black J; Mehta R; Parker A; Chikobvu P; Dawood H; Muvhango N; Strydom R; Adelekan T; Mdlovu B; Moodley N; Namavhandu EL; Rheeder P; Venturas J; Magula N; Blumberg L;
    Lancet HIV; 2021 Sep; 8(9):e554-e567. PubMed ID: 34363789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of cancer on the severity of disease in patients affected with COVID-19: an umbrella review and meta-meta-analysis of systematic reviews and meta-analyses involving 1,064,476 participants.
    Arayici ME; Basbinar Y; Ellidokuz H
    Clin Exp Med; 2023 Oct; 23(6):2221-2229. PubMed ID: 36207550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence.
    Carle C; Hughes S; Freeman V; Campbell D; Egger S; Caruana M; Hui H; Yap S; Deandrea S; Onyeka TC; IJzerman MJ; Ginsburg O; Bray F; Sullivan R; Aggarwal A; Peacock SJ; Chan KKW; Hanna TP; Soerjomataram I; O'Connell DL; Canfell K; Steinberg J
    J Cancer Policy; 2022 Sep; 33():100338. PubMed ID: 35671919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality risk factors of COVID-19 infection in kidney transplantation recipients: a systematic review and meta-analysis of cohorts and clinical registries.
    Udomkarnjananun S; Kerr SJ; Townamchai N; Susantitaphong P; Tulvatana W; Praditpornsilpa K; Eiam-Ong S; Avihingsanon Y
    Sci Rep; 2021 Oct; 11(1):20073. PubMed ID: 34625642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Patients' Epidemiological Characteristics and Comorbidities with Severity and Related Mortality Risk of SARS-CoV-2 Infection: Results of an Umbrella Systematic Review and Meta-Analysis.
    Reyna-Villasmil E; Caponcello MG; Maldonado N; Olivares P; Caroccia N; Bonazzetti C; Tazza B; Carrara E; Giannella M; Tacconelli E; Rodríguez-Baño J; Palacios-Baena ZR;
    Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.